BridgeMD
New treatment option for Cervical Cancer
Official title Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
ClinicalTrials.gov ID: NCT05427058
What this study is testing
- What it's testing
- This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
- The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced...
- Patients with pelvic floor pain diagnosed by a (Fellow of treatment Pain Practice) FIPP-certified pain specialist
- Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
- Numerical Rating Scale \>4
You likely can't join if
- Refuse to be included in the research
- Blood clotting disorders (including taking anticoagulant drugs)
- Local infection in the area of action
- Loss to follow up Drop-out Criteria:
- Loss to follow up
- Intervention complications occur
See the full eligibility criteria
- Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
- The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
- Patients with pelvic floor pain diagnosed by a (Fellow of treatment Pain Practice) FIPP-certified pain specialist
- Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
- Numerical Rating Scale \>4
- \>18 years old
- Able and willing to sign an informed consent
- Refuse to be included in the research
- Blood clotting disorders (including taking anticoagulant drugs)
- Local infection in the area of action
- Loss to follow up Drop-out Criteria:
- Loss to follow up
- Intervention complications occur
- Failed intervention
The study team makes the final eligibility decision.
Where it's taking place
- Malang, East Java, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Malang, East Java, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.